CEOBuys,,2019-05-20 14:40:00,96.784,Check out ceobuyscom to learn more about EXASs CEO Since 2014 they bought shares 1 time
Cvrdcall1,True,2019-05-20 12:00:00,97.502,EXAS good move up Called out Friday on half my position at 94 plus premium Still holding 100 shares long May sell covered call if we break 100 105 EOM
elitecore,True,2019-05-20 11:51:00,98.06,EXAS Exact Sciences Mayo Clinic Collaboration Find Potential HighSensitivity Biomarker for Pancreatic Cancer The results of a 340sample casecontrol study using bloodbased methylated DNA markers in plasma in combination with cancer antigen 199 showed significantly better sensitivity and specificity in detecting pancreatic ductal adenocarcinoma than when cancer antigen is used on its own
elitecore,,2019-05-20 11:43:00,97.063,EXAS The Exact Sciences and Mayo Clinic collaboration focuses on identifying biomarkers for 15 of the deadliest cancers A poster showing Mayo Clinic researchers work on esophageal cancer will also be presented at DDW
elitecore,True,2019-05-20 11:42:00,97.005,EXAS Exact Sciences Advances Pipeline Capabilities with Mayo Clinic financeyahoocomnewsexac
TalonStrike,True,2019-05-20 11:00:00,97.13,EXAS good news and good response on a risk off day R1105106 top of LT Ascend Chl S1 9450d MA S28889100d MA
EstimizeAlerts,,2019-05-20 10:54:00,96.713,EXAS estimates distribution heres what 8 Estimize analysts are expecting EXAS to report for Q2 Reporting 0731 AMCestimizecomintroexascha
streetbrief,,2019-05-20 09:44:00,94.51,EXAS Note according to cancergov New Colon Cancer cases in 2017 was 135430 Est for 2019 is 145600 So looks like products form EXAS are helping to find cases earlier and saving lives Thats a very good thing
streetbrief,,2019-05-20 09:43:00,94.573,EXAS Looks like Pancreatic Cancer ranks up high in the list New cases 2019 56770 vs Colon Cancer 145600 All Cancers 32 Deaths per year 45750 All Cancer deaths 75
